BIOMAT Database Logo BIOMAT Database Logo

Increased mitogenic response to heparin-binding epidermal growth factor-like growth factor in vascular smooth muscle cells of diabetic rats. 1995

K Fukuda, and Y Inui, and S Kawata, and S Higashiyama, and Y Matsuda, and Y Maeda, and T Igura, and S Yoshida, and N Taniguchi, and Y Matsuzawa
Second Department of Internal Medicine, Osaka University Medical School, Japan.

We investigated the mitogenic effects of heparin-binding epidermal growth factor-like growth factor (HB-EGF) in vascular smooth muscle cells (SMCs) obtained from rats with streptozotocin (STZ)-induced diabetes and evaluated the role of heparan sulfate proteoglycan (HSPG) in inducing these effects. HB-EGF significantly increased DNA synthesis in the SMCs of diabetic rats (STZ-SMCs) compared with control rats (control SMCs). However, the mitogenic effects of EGF, which shares EGF receptors with HB-EGF, and basic fibroblast growth factor, another heparin-binding growth factor, were similar in STZ-SMCs and control SMCs. The mitogenic response to HB-EGF in SMCs of insulin-treated diabetic rats was similar to the response in control SMCs. HB-EGF-induced autophosphorylation of EGF receptors was increased in STZ-SMCs compared with control SMCs, although the number of EGF receptors in STZ-SMCs was 40% of that in controls. This increased mitogenic response to HB-EGF in STZ-SMCs was completely inhibited by treatment with heparitinase, chlorate, and a synthetic peptide corresponding to the heparin-binding domain of HB-EGF. Compared with heparan sulfate isolated from control SMCs, heparan sulfate isolated from STZ-SMCs was of smaller molecular size and caused a greater mitogenic effect of HB-EGF. These findings suggest that the mitogenic response to HB-EGF is increased in SMCs of diabetic rats. Changes in cell-associated heparan sulfate in STZ-SMCs may be related to the increased mitogenic response to HB-EGF.

UI MeSH Term Description Entries
D008297 Male Males
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

K Fukuda, and Y Inui, and S Kawata, and S Higashiyama, and Y Matsuda, and Y Maeda, and T Igura, and S Yoshida, and N Taniguchi, and Y Matsuzawa
Signaling mechanisms of heparin-binding epidermal growth factor-like growth factor in vascular smooth muscle cells.
February 2002, Hypertension (Dallas, Tex. : 1979),
K Fukuda, and Y Inui, and S Kawata, and S Higashiyama, and Y Matsuda, and Y Maeda, and T Igura, and S Yoshida, and N Taniguchi, and Y Matsuzawa
Intercellular communication between vascular smooth muscle and endothelial cells mediated by heparin-binding epidermal growth factor-like growth factor and vascular endothelial growth factor.
April 1998, FEBS letters,
K Fukuda, and Y Inui, and S Kawata, and S Higashiyama, and Y Matsuda, and Y Maeda, and T Igura, and S Yoshida, and N Taniguchi, and Y Matsuzawa
Heparin-binding epidermal growth factor-like growth factor regulates fibroblast growth factor-2 expression in aortic smooth muscle cells.
August 1996, Circulation research,
K Fukuda, and Y Inui, and S Kawata, and S Higashiyama, and Y Matsuda, and Y Maeda, and T Igura, and S Yoshida, and N Taniguchi, and Y Matsuzawa
Vascular endothelial growth factor induces heparin-binding epidermal growth factor-like growth factor in vascular endothelial cells.
February 1998, The Journal of biological chemistry,
K Fukuda, and Y Inui, and S Kawata, and S Higashiyama, and Y Matsuda, and Y Maeda, and T Igura, and S Yoshida, and N Taniguchi, and Y Matsuzawa
Heparin-like molecules regulate the number of epidermal growth factor receptors on vascular smooth muscle cells.
July 1988, Journal of cellular physiology,
K Fukuda, and Y Inui, and S Kawata, and S Higashiyama, and Y Matsuda, and Y Maeda, and T Igura, and S Yoshida, and N Taniguchi, and Y Matsuzawa
Increased expression of heparin binding epidermal growth-factor-like growth factor mRNA in the kidney of streptozotocin-induced diabetic rats.
February 1995, Biochemical and biophysical research communications,
K Fukuda, and Y Inui, and S Kawata, and S Higashiyama, and Y Matsuda, and Y Maeda, and T Igura, and S Yoshida, and N Taniguchi, and Y Matsuzawa
Heparin-binding EGF-like growth factor synthesis by smooth muscle cells.
January 1994, Hormone research,
K Fukuda, and Y Inui, and S Kawata, and S Higashiyama, and Y Matsuda, and Y Maeda, and T Igura, and S Yoshida, and N Taniguchi, and Y Matsuzawa
Induction of macrophage colony-stimulating factor receptor (c-fms) expression in vascular medial smooth muscle cells treated with heparin binding epidermal growth factor-like growth factor.
October 1996, The Journal of biological chemistry,
K Fukuda, and Y Inui, and S Kawata, and S Higashiyama, and Y Matsuda, and Y Maeda, and T Igura, and S Yoshida, and N Taniguchi, and Y Matsuzawa
Heparin-binding epidermal growth factor-like growth factor expression in cultured fetal human vascular smooth muscle cells. Induction of mRNA levels and secretion of active mitogen.
August 1993, The Journal of biological chemistry,
K Fukuda, and Y Inui, and S Kawata, and S Higashiyama, and Y Matsuda, and Y Maeda, and T Igura, and S Yoshida, and N Taniguchi, and Y Matsuzawa
Suppression of 3-deoxyglucosone and heparin-binding epidermal growth factor-like growth factor mRNA expression by an aldose reductase inhibitor in rat vascular smooth muscle cells.
February 2004, Biochemical and biophysical research communications,
Copied contents to your clipboard!